# Conditioning Regimen Containing Low Dose ATG for The Treatment of Acquired SAA Receiving sUCBT

> **NCT06039436** · — · UNKNOWN · sponsor: **Anhui Provincial Hospital** · enrollment: 72 (estimated)

## Conditions studied

- Severe Aplastic Anemia

## Interventions

- **DRUG:** Anti-Thymocyte Globulin (Rabbit)

## Key facts

- **NCT ID:** NCT06039436
- **Lead sponsor:** Anhui Provincial Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10
- **Primary completion:** 2025-04-30
- **Final completion:** 2025-05-31
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2023-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06039436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06039436, "Conditioning Regimen Containing Low Dose ATG for The Treatment of Acquired SAA Receiving sUCBT". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06039436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*